Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Systematic comparisons between Lyme disease and post-treatment Lyme disease syndrome in the U.S. with administrative claims data

EBioMedicine(2023)10.1016/j.ebiom.2023.104524Source: DataRank Database

Systematic comparisons between Lyme disease and post-treatment Lyme disease syndrome in the U.S. with administrative claims data is a dataset published in EBioMedicine (2023). On theSindex it has a DataRank of 0.654, placing it in the top 30.5% of the data-sharing corpus. It has been cited 18 times, with 16 citing works in its 1-hop citation network.

Top 30%percentile

0.654DataRank

Ranks in the top 30% for downstream scientific impact

Data paper Open Access18 citations · 16 citing works in its network

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 4.25)OA: goldTopics (31)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (1/3)

Dataset classification

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 68%Citation Network 32%

Base Score Contribution

0.442

From this paper's citation signal

Citation Network Contribution

0.212

From 10 citing papers with measurable signal

Learn more about DataRank methodology →

Top 5 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 16 citers.

Rapid Increase in Seroprevalence of Borrelia burgdorferi Antibodies among Dogs, Northwestern North Carolina, USA, 2017–20211
Emerging infectious diseases20243 citations26 referencesContributes 0.053
A Lyme disease mRNA vaccine targeting Borrelia burgdorferi OspA induces strong immune responses and prevents transmission in mice
Molecular Therapy — Nucleic Acids202514 citations68 referencesContributes 0.040
Antimicrobial cyclic peptides effectively inhibit multiple forms of Borrelia and cross the blood-brain barrier model
Scientific Reports20259 citations71 referencesContributes 0.032
Optimizing Exclusion Criteria for Clinical Trials of Persistent Lyme Disease Using Real-World Data
Healthcare20243 citations47 referencesContributes 0.029
Identification of Major Histocompatibility Complex Class II Epitopes From Lyme Autoantigen Apolipoprotein B-100 and Borrelia burgdorferi Mcp4 in Murine Lyme Arthritis
The Journal of Infectious Diseases20243 citations50 referencesContributes 0.028

Authors (6)

Mariaelena Caboni ORCID,Philip Strandwitz ORCID,Anthony D’Onofrio ORCID,Kim Lewis ORCID,Chirag J. Patel ORCID

Live enrichment

PubMed:36958992 PMC:PMC10114153 OpenAlex:https://openalex.org/W4328089203

National Institutes of Health

Grant: R01ES032470

NIAID NIH HHS

Grant: R01 AI127250

FWCI

4.25

Citation Percentile

0.9%

Citation Trend

2023

2024

2025

2026

goldLicense: cc-by

journalhttp://www.thelancet.com/article/S2352396423000890/pdf

publisherhttp://www.thelancet.com/article/S2352396423000890/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2352396423000890?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2352396423000890?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.ebiom.2023.104524

Fields of Study

Vector-borne infectious diseasesComplement system in diseasesLong-Term Effects of COVID-19HumansPost-Lyme Disease SyndromeLyme DiseaseAnti-Bacterial AgentsChronic DiseasePain

MeSH Terms

Post-Lyme Disease SyndromeAnti-Bacterial AgentsChronic DiseaseHumansLyme DiseasePain

Keywords

MedicineLyme diseaseBorrelia burgdorferiInternal medicineComorbidityEpidemiologyOdds ratioIncidence (geometry)DermatologyImmunologyEhrAdministrative DataClaims DataChronic Lyme DiseasePost-treatment Lyme Disease SyndromePtlds

Sustainable Development Goals

SDG 0: Good health and well-being

Systematic comparisons between Lyme disease and post-treatment Lyme disease syndrome in the U.S. with administrative claims data

FAIR Checklist

DataRank Breakdown

Top 5 citers driving the network score

Authors (6)

Funding (2 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)